Award Presented at AAM Access! 2025 on February 5
Amelia Island, Florida – February 5, 2025 – Lachman Consultants is proud to celebrate Robert Pollock, M.S., who was honored with the prestigious Lifetime Achievement Award from the Association for Accessible Medicines (AAM) at AAM’s Access! 2025 conference. This esteemed recognition highlights Bob’s decades of dedication to improving patient access to safe, effective, and affordable medicines.
As a longtime member of Lachman Consultants’ Board of Directors and a cornerstone of the company for decades, Bob has been a guiding force in shaping regulatory and industry strategies that have expanded access to generic and biosimilar medicines. His deep expertise and commitment to the pharmaceutical industry have left a lasting impact, helping to make medications more affordable and accessible for millions.
“Bob’s contributions to our industry are immeasurable,” said Frances M. Zipp, President & CEO of Lachman Consultants. “His leadership, integrity, and passion for ensuring patient access to high-quality medicines have made a significant difference. We are thrilled to see him receive this well-deserved honor.”
The Lifetime Achievement Award is AAM’s highest distinction, recognizing individuals whose careers have exemplified leadership and unwavering commitment to increasing patient access to lower-cost medications.
The award was presented during AAM Access! 2025, the industry’s premier event bringing together key stakeholders, policymakers, and healthcare advocates to advance the future of affordable medicines.
Lachman Consultants congratulates Bob on this remarkable achievement and thanks him for his continued contributions to both our firm and the broader pharmaceutical community.
####
About Robert Pollock, M.S.
Robert Pollock, M.S. is an Outside Director of the LCS Board of Directors. He joined Lachman Consultants following a distinguished career with the FDA and the Public Health Service. His FDA experience, culminating as the Acting Deputy Director of the Office of Generic Drugs, enables him to provide expert advice and assistance on all aspects of FDA and Regulatory filings. Mr. Pollock is well-versed in the intricacies of International Harmonization Issues, regulatory strategies, standards and filing issues, resolution of FDA regulatory matters, as well as in the resolution of patent / exclusivity issues.
About Lachman Consultants
For more than 45 years, Lachman Consultants has been a trusted leader in providing expert regulatory, compliance, and technical consulting to the pharmaceutical, biologics, and related healthcare industries. Our team of experts helps organizations navigate complex regulatory environments to ensure the delivery of safe, effective, and high-quality medicines to patients worldwide.
For media inquiries, please contact:
Matthew Taylor
Lachman Consultant Services, Inc.
www.LachmanConsultants.com
m.taylor@lachmanconsultants.com
